Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBsAg clearance-directed personalized treatment strategy in HBeAg-negative chronic hepatitis B
ChiCTR-OPN-17012515Phase 4Recruiting
- Sponsor
- Beijing YouAn Hospital
- Start
- Oct 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of pegylated interferon alpha in Chronic Hepatitis B (CHB) (2 arms), sponsored by Beijing YouAn Hospital. Primary endpoint: HBsAg clearance rate. Started Oct 2017; status: recruiting.
02
Drugs
pegylated interferon alpha
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-OPN-17012515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-17012515.